{"ticker": {"uuid": "1337931f-d27e-4c1b-bf1b-2ba0166ad857", "symbol": "ACET", "name": "Adicet Bio Inc", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Is Adicet Bio (ACET) stock outpacing its medical peers this year?", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxPTkN2dkVTMlZtOU1qNmMzclVvcVo1dVNlN0J4QTQ4U0xScWxCRjdtSElqdUdReDI5a1V0V1ptc004RS1rdDNsMVlkQmx0N0F5MnB3c3J5dUtpLXE3Z3gwaklSb1BYVFk2bEZiSHQ5UGdmekxVdU85Q2hEampKQXpTV2hSbWJYdVBHVm9uSm5GNnpMYnVYX0Q2RmVGYXJVeU95QXpDMVIzdkpRSElfNEhyM0R5akx6S0VpWldlcW9SdEdjMWx0dHFxaEZDeWlTdw?oc=5", "source_name": "MSN", "published_at": "2026-07-13T16:51:12+00:00", "published_display": "13 Jul 2026 16:51", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Price to earnings forward of Adicet Bio, Inc. \u2013 NASDAQ:ACET", "summary": "This page provides financial information for Adicet Bio, Inc. (NASDAQ: ACET), specifically focusing on its forward price-to-earnings ratio. The content appears to be from TradingView, offering a snapshot of financial data and market status for the company.", "url": "https://www.tradingview.com/symbols/NASDAQ-ACET/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-07-11T09:39:49", "published_display": "11 Jul 2026 09:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Adicet Bio (ACET) Proxy filing Summary", "summary": "This article summarizes Adicet Bio's proxy filing, detailing the annual meeting scheduled for June 17, 2026. Key items for shareholder voting include the election of three Class II directors, an advisory vote on executive compensation, and the ratification of KPMG LLP as the inde", "url": "https://quartr.com/events/adicet-bio-inc-acet-proxy-filing_FkPWORTG", "source_name": "Quartr", "published_at": "2026-07-09T17:12:03", "published_display": "09 Jul 2026 17:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Adicet Bio (ACET) Stock Analysis Report | Financials & Insights", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFAxT0x4TVJGRmZ0QmtBMGFjcWFjRGpnMFNESGs5cUM2dm92VVhLUmwtOU55cVdkcjNmVWMwYlcxRlpKcnJnYV9YZjc4X1VuSmhPMGU0?oc=5", "source_name": "Benzinga Espa\u00f1a", "published_at": "2026-07-03T07:00:00+00:00", "published_display": "03 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Adicet Bio, Inc.(NasdaqCM: ACET) added to Russell 3000E Index", "summary": "Adicet Bio, Inc. (NasdaqCM: ACET), a clinical-stage biotechnology company, has been added to the Russell 3000E Index. The company focuses on developing off-the-shelf gamma delta T cells engineered with chimeric antigen receptors (CARs) for autoimmune diseases and solid tumors. It", "url": "https://www.marketscreener.com/news/adicet-bio-inc-nasdaqcm-acet-added-to-russell-3000e-index-ce7f5fdcda8ef226", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T21:09:58", "published_display": "29 Jun 2026 21:09", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Adicet Bio, Inc.(NasdaqCM: ACET) added to Russell 3000E Value Benchmark", "summary": "Adicet Bio, Inc. (NasdaqCM: ACET) has been added to the Russell 3000E Value Benchmark. This news follows earlier announcements that the company was also added to the Russell Microcap Value Benchmark Index and the Russell Microcap Index on June 29, 2026, and the Russell 3000E Inde", "url": "https://www.marketscreener.com/news/adicet-bio-inc-nasdaqcm-acet-added-to-russell-3000e-value-benchmark-ce7f5fddda8df521", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T20:41:48", "published_display": "29 Jun 2026 20:41", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Adicet Bio, Inc.(NasdaqCM: ACET) added to Russell Microcap Value Benchmark Index", "summary": "Adicet Bio, Inc. (NasdaqCM: ACET) has been added to the Russell Microcap Value Benchmark Index. The clinical-stage biotechnology company focuses on developing off-the-shelf gamma delta T cell therapies, with its lead product candidate, ADI-001, targeting autoimmune diseases. This", "url": "https://www.marketscreener.com/news/adicet-bio-inc-nasdaqcm-acet-added-to-russell-microcap-value-benchmark-index-ce7f5fdfd988f621", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T13:40:02", "published_display": "29 Jun 2026 13:40", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Adicet Bio Inc Actuals & Estimates (MUN:1IJ)", "summary": "This article provides an overview of Adicet Bio Inc (MUN:1IJ) stock, including financial actuals and analyst estimates. It covers the company's past performance, future price forecasts, earnings reports, revenue, net income, and employee count. The article also provides details o", "url": "https://www.tradingview.com/symbols/MUN-1IJ/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T19:09:59", "published_display": "26 Jun 2026 19:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ACET Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "The article provides a forecast for Adicet Bio, Inc. (ACET) stock, including analyst price targets, historical performance, and current financial metrics. Analysts have given ACET a max estimate of $100.00 and a min estimate of $18.00. The company's recent stock performance and u", "url": "https://www.tradingview.com/symbols/NASDAQ-ACET/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-26T19:09:59", "published_display": "26 Jun 2026 19:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "1IJ Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast for Adicet Bio Inc (1IJ) stock, including analyst price targets and future predictions. It details the company's past financial performance, upcoming earnings dates, and current employee count. The article also addresses frequently asked questions", "url": "https://www.tradingview.com/symbols/DUS-1IJ/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-26T18:10:27", "published_display": "26 Jun 2026 18:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Adicet Bio Inc Actuals & Estimates (TRADEGATE:1IJ)", "summary": "This article provides financial actuals and estimates for Adicet Bio Inc (TRADEGATE:1IJ), including income statements, balance sheets, cash flow data, and valuations. It also offers analyst forecasts, historical price data, upcoming earnings reports, and other key financial metri", "url": "https://www.tradingview.com/symbols/TRADEGATE-1IJ/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T06:10:27", "published_display": "26 Jun 2026 06:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "12 Health Care Stocks Moving In Thursday's Pre-Market Session", "summary": "This article lists 12 healthcare stocks experiencing significant movement in pre-market trading on Thursday. It details both gainers like Adicet Bio, Bio-Techne, and TELA Bio, noting their percentage increase and market values. Conversely, it also highlights decliners such as ARS", "url": "https://www.benzinga.com/trading-ideas/movers/26/06/60093829/12-health-care-stocks-moving-thursday-s-pre-market-session", "source_name": "Benzinga", "published_at": "2026-06-25T11:40:23", "published_display": "25 Jun 2026 11:40", "sentiment": "positive", "sentiment_pct": 75, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Adicet Bio (ACET) director receives 4,200 stock options at $8.10 strike", "summary": "Adicet Bio director Andrew Sinclair was granted 4,200 stock options at an exercise price of $8.10 per share as part of his board compensation. These options, which expire on June 20, 2036, will vest fully on the earlier of the first anniversary of the grant date or the next annua", "url": "https://www.stocktitan.net/sec-filings/ACET/form-4-adicet-bio-inc-insider-trading-activity-c0c44bfdd479.html", "source_name": "Stock Titan", "published_at": "2026-06-24T18:09:17", "published_display": "24 Jun 2026 18:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Adicet Bio (ACET) CEO Chen Schor receives 55,000 stock options at $8.10", "summary": "Chen Schor, President & CEO of Adicet Bio (ACET), has been granted a new stock option award for 55,000 shares. These options have an exercise price of $8.10 per share and will vest monthly over four years, with potential for accelerated vesting based on specific performance miles", "url": "https://www.stocktitan.net/sec-filings/ACET/form-4-adicet-bio-inc-insider-trading-activity-ddd9b53cd813.html", "source_name": "Stock Titan", "published_at": "2026-06-23T23:09:27", "published_display": "23 Jun 2026 23:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Adicet Bio Inc For: 23 June By Investing.com", "summary": "This article from Investing.com reports the filing of a Form 4 for Adicet Bio Inc. on June 23. Form 4 filings are legally required documents submitted to the SEC by company insiders, like officers and directors, to report changes in their ownership of the company's restricted sto", "url": "https://ca.investing.com/news/stock-market-news/form-4-adicet-bio-inc-for-23-june-93CH-4704405", "source_name": "Investing.com Canada", "published_at": "2026-06-23T23:09:27", "published_display": "23 Jun 2026 23:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Adicet Bio (ACET) grants CSO Blake Aftab 55,000 stock options", "summary": "Adicet Bio, Inc. has granted its Chief Scientific Officer, Blake Aftab, 55,000 stock options with an exercise price of $8.10 per share, expiring on June 18, 2036. These options are compensation-related and will vest over 48 monthly anniversaries of the grant date, with potential ", "url": "https://www.stocktitan.net/sec-filings/ACET/form-4-adicet-bio-inc-insider-trading-activity-4dc47a629a72.html", "source_name": "Stock Titan", "published_at": "2026-06-23T23:09:27", "published_display": "23 Jun 2026 23:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Adicet Bio (ACET) director receives stock options for 4,200 shares at $8.10", "summary": "Adicet Bio director Michael Grissinger was granted stock options for 4,200 shares of common stock at an exercise price of $8.10 per share, expiring on June 20, 2036. This compensation-related grant will vest in full on the earlier of the first anniversary of the grant date or the", "url": "https://www.stocktitan.net/sec-filings/ACET/form-4-adicet-bio-inc-insider-trading-activity-8446e4ea96ab.html", "source_name": "Stock Titan", "published_at": "2026-06-23T20:09:57", "published_display": "23 Jun 2026 20:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Director Katie Peng receives 4,200 Adicet Bio (ACET) stock options at $8.10", "summary": "Adicet Bio director Katie Peng was granted 4,200 stock options with an exercise price of $8.10 per share, set to expire on June 20, 2036. The options will vest fully on the earlier of the first anniversary of the grant date or the next annual stockholders' meeting, provided her c", "url": "https://www.stocktitan.net/sec-filings/ACET/form-4-adicet-bio-inc-insider-trading-activity-8ec43dd497e1.html", "source_name": "Stock Titan", "published_at": "2026-06-23T20:09:27", "published_display": "23 Jun 2026 20:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Director at Adicet Bio (NASDAQ: ACET) receives 4,200 stock options grant", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxOdmJ3d2lqbDg2c0lQSnZvV0pvYkN4UG1RYWc4UXdQVi1QWGJrY3dHc2xTdVZyLUxfWEJJempvRGhjMlVpVi1TbHp0cVlualNEbHBfRFZRekxia2hmYXJMakQ0WjZVYndIN3dmS1JpWnA3Z2FPRXRuckRQQklvR3F3RkJyZ1R5OHFHaHJfN0xqemQ0LWhlWmhkWkpVbXFpUU84VGg2ckQ4d012Rmc5?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Director at Adicet Bio (ACET) awarded 4,200 options at $8.10 strike", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxOclo5S1k0dVhzTnBVUnJoUGcxZjA5d0VnSVZvTnVSXy1SeDFFdENCM0JrSEFDbVRDSGRaeVVERkdDNU9KX0xJY3dWbjZJTHl1ZDhzZmE5X3Uyd1Vtdl9jME1VTDRndktSUkhMNW1HeWNpa1Z3R01paHNMUnpyRVMzbG5WVzRraThMd3VkSmkzWnh0d1hoZE5CbGpJcm8yTlpocFl1d3ZnWlVqTTVf?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Adicet Bio (ACET) investors back board nominees, pay and KPMG at 2026 meeting", "summary": "Adicet Bio, Inc. (ACET) held its 2026 Annual Meeting of Stockholders, where shareholders approved the election of three Class II directors, Jeffrey Chodakewitz, Steve Dubin, and Michael Grissinger, to three-year terms. They also passed a non-binding advisory vote on the compensat", "url": "https://www.stocktitan.net/sec-filings/ACET/8-k-adicet-bio-inc-reports-material-event-ffdcdae26276.html", "source_name": "Stock Titan", "published_at": "2026-06-18T19:40:48", "published_display": "18 Jun 2026 19:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Adicet Bio Inc (ACET) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides an overview of Adicet Bio Inc's (ACET) dividend history and stock split events. It indicates that the company has not distributed any dividends in the past five years but lists several past merger-related stock splits. The company's current market capitaliza", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-acet/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-18T06:39:51", "published_display": "18 Jun 2026 06:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Adicet Bio Inc (ACET) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "The article provides an earnings forecast for Adicet Bio Inc (ACET), indicating a current earnings forecast score of 9.00 and an average price target of $8.00 based on 6 analysts. Most analysts recommend a \"STRONG BUY\" for ACET stock, with a projected upside space of over 348%. T", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-acet/earnings", "source_name": "TradingKey", "published_at": "2026-06-18T05:39:51", "published_display": "18 Jun 2026 05:39", "sentiment": "positive", "sentiment_pct": 72, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ACET: All proposals, including director elections and auditor ratification, were approved by stockholders", "summary": "Adicet Bio, Inc. (ACET) stockholders approved all proposals, including director elections, executive compensation, and auditor ratification, during their 2026 AGM. The meeting established quorum and no questions were raised. Final voting results will be officially filed.", "url": "https://www.tradingview.com/news/urn:summary_document_transcript:quartr.com:3611343:0-acet-all-proposals-including-director-elections-and-auditor-ratification-were-approved-by-stockholders/", "source_name": "TradingView", "published_at": "2026-06-18T04:09:39", "published_display": "18 Jun 2026 04:09", "sentiment": "positive", "sentiment_pct": 68, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Adicet Bio Inc (ACET) Valuation: PE, PB & Fair Value Analysis", "summary": "This article provides a valuation analysis for Adicet Bio Inc (ACET), noting its current valuation score of 8.21, ranking 161 out of 388 in the Biotechnology & Medical Research industry. It highlights the company's P/E ratio of -0.58, which is significantly below its recent high ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-acet/company-valuation", "source_name": "TradingKey", "published_at": "2026-06-17T02:38:56", "published_display": "17 Jun 2026 02:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "10 Health Care Stocks Moving In Monday's Pre-Market Session - Adicet Bio (NASDAQ:ACET), 20/20 Biolabs (NA", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxNY1NkOEFvb2RTcFdiRnp3TVdEQjN1QkdyckY3d2w5VU5QZ3JEVnRaQ001X3FSVWRvSExSMHFqOTNreGM0MXB1d3pCNE9HNW1Ra3pMRDM4R3hhTmFpMERKRXpIZ3hSWmRzU2VCQWUxcThHdEJ0elBEdGRYN3BvRUp0eVlQdDFXNk51YzBTQ0JOSDdTSVlGRVlld0FrdnJJc1NTRXhCanlqSVJkSWZDZjU2NlBGVmo?oc=5", "source_name": "Benzinga", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Adicet Bio teases autoimmune data catalysts, PSMA plans at Jefferies conference", "summary": "The provided article content was empty. Therefore, a summary cannot be generated.", "url": "https://www.msn.com/en-us/health/other/adicet-bio-teases-autoimmune-data-catalysts-psma-plans-at-jefferies-conference/ar-AA24Qz6r?ocid=BingNewsVerp&apiversion=v2&domshim=1&noservercache=1&noservertelemetry=1&batchservertelemetry=1&renderwebcomponents=1&wcseo=1", "source_name": "MSN", "published_at": "2026-06-09T11:40:03", "published_display": "09 Jun 2026 11:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Adicet Bio (ACET) Jefferies Global Healthcare Conference 2026 Summary", "summary": "The article summarizes Adicet Bio's presentation at the Jefferies Global Healthcare Conference 2026, focusing on their gamma delta T cell platform and clinical progress. Key updates include their lead candidate, prula-cel (ADI-001), being evaluated for several autoimmune indicati", "url": "https://quartr.com/events/adicet-bio-inc-acet-jefferies-global-healthcare-conference-2026_FkPWOMcq", "source_name": "Quartr", "published_at": "2026-06-07T15:41:00", "published_display": "07 Jun 2026 15:41", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BPAS - Adicet Bio, Inc. - Common Stock (Nasdaq:ACET) Stock Quote", "summary": "This page provides a stock quote and detailed financial information for Adicet Bio, Inc. (Nasdaq: ACET), including current price, volume, trading ranges, and market capitalization. It also features a comprehensive list of recent news and press releases related to the company's fi", "url": "https://markets.financialcontent.com/bpas/quote?Symbol=NQ%3AACET", "source_name": "FinancialContent", "published_at": "2026-06-06T10:38:56", "published_display": "06 Jun 2026 10:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BPAS - Latest News about Adicet Bio, Inc. - Common Stock (Nasdaq:ACET)", "summary": "This page provides the latest news and press releases concerning Adicet Bio, Inc. (Nasdaq: ACET), detailing various corporate updates, financial results, conference participations, and clinical trial milestones. The stock price for Adicet Bio, Inc. is also displayed, showing a re", "url": "https://markets.financialcontent.com/bpas/quote/news?Symbol=537%3A903118&ChannelType=PRESSRELEASES", "source_name": "FinancialContent", "published_at": "2026-06-05T22:10:07", "published_display": "05 Jun 2026 22:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Are Medical Stocks Lagging Adicet Bio (ACET) This Year?", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxPaTdVLUVzSHFNQnM4ZmN1SmVuNUJkUGJMR3VlMWl1TmVzTllzNl9SZllkaHBraGJ6N1g0THltc2EtSmlubW1aUVhMaXBzQ1JyNUFOSkptRWNVajhVRmVfVTIxLTJza1ZVQ2VKWmQyZlJHMjlJQjRSRXg4c2hYRHc0aGJBZDc5b2hNSGU0OE12TEtjdXktR0k1WjRjY2VXaTZrOFh0Vg?oc=5", "source_name": "Market source", "published_at": "2026-05-28T07:00:00+00:00", "published_display": "28 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Wall Street Analysts Believe Adicet Bio (ACET) Could Rally 319.64%: Here's is How to Trade", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxQTDZkM1d6WFFIM2tCWkJCOVhxM3oyOEpWZ1dMS1Q0bTFWWHlOQ0lrTHFUcXVPTGpmSGY1Vld4ZFZvYjlTSC1MZXZWQWU0Q1NnaTM0Z0Z1dUlqN0k3ZHRkeElJMVBtaFI5bDdVNnFGM2pZUUFsOXFQUjZFMlBWa0s3ZF91dlBEVGYyeG56aGdoSF9IWlVJdF9SR0hHVk1mOGdyeEE?oc=5", "source_name": "Market source", "published_at": "2026-05-25T07:00:00+00:00", "published_display": "25 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Ra Capital buys Adicet Bio (ACET) shares worth $1.6 million", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxPekE1Z05VTzZvYkNHbGFSNEdiNzdFa01sZVZTbHdsUzRlSFFsSmVoQk5JUHdwN3B3MjFLVkhfZzM1YWRNODVWZm5obGdKMjFETXJITVlGZ1p2el9WUGtUdEQ1YW9ONlVhaDNZQkd1VU8xVVR4NDhxUjctVVJTenJKZ3FUYXJOZzZCVEFXelRSTENWd1h0SE9xUWJRR2diakI3Tllwc2FlMTYxNTg0em1fVXYxQUN1eTQ0X3B1ag?oc=5", "source_name": "Investing.com", "published_at": "2026-04-13T07:00:00+00:00", "published_display": "13 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Adicet Bio (ACET) Upgraded to Buy: Here's Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPa1pKWmU5MWRTeXZPcDhnZldhM0tjNjdtNXpacEdaUEFrUDZUZmRseXVKUFJGcHRCVGdUcF9maldZMWFLSTJ6czlLRUxTdmxHOVVreHAxU2JLRTRoR1Y2S2VNb0lFUm5pR1ctZ1M5X3l0Ym1NMnc5T1VvYmVIcl9WUmxzYnk3SXV4Z0gxMEVMZDBHVXR4ZjZJNQ?oc=5", "source_name": "Market source", "published_at": "2026-03-24T07:00:00+00:00", "published_display": "24 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 84, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orbimed advisors buys Adicet Bio (ACET) shares worth $5 million", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxPU0Z4blctSWJnbnFJTlVuWDAyYUU2a2NYWGs5T015aW9DQWh5VldVbmhMX0J4UGEyRW5ua1h5U2F5YmZyTW54LXhPaFM4Q1B4aVdHRGRNekphZnBEZjB4VU5CWmwxcWZxbzJsVE02bXRDeFdNNU5QN241SFU0YUlJSF9vRjV6VjdoZFNEZFJ6Ykw4OElsNmEzX256TUU5dUxrWXRZMmdBZWdyVjBCeWsxc2ljREhPdk1wdlRjeElmb0N3clE?oc=5", "source_name": "Investing.com", "published_at": "2025-10-10T07:00:00+00:00", "published_display": "10 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Adicet Bio (ACET) Upgraded to Buy: Here's What You Should Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMif0FVX3lxTE5fOFRRbGF4dWFMbS1KS2xPOTd6c2FIMWgxWUhWbXVONVZ1SWdndEJFQ0x0My1PNmgteW1xQ1p3RTkxR29KYUNVSDZNd0xqZkJrcjBzMDFYVWtUZlp5c2QyNHMtV01uNUdubVNUVDU1aUYzMEl0MXdBQVNRdWlNRVU?oc=5", "source_name": "Market source", "published_at": "2025-09-30T07:00:00+00:00", "published_display": "30 Sep 2025 07:00", "sentiment": "positive", "sentiment_pct": 84, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Adicet Bio (ACET) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFBHMEx6VmJMMGlnNDdxT1VWQVFOdHdRd3FsblBBR2g3OW5yUVI2c3o2MkxfdFhjbWFjaGYzUjdUSEE3LVhlSVVUeUl1WFcyWjV3YWlr?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-25T00:00:05+00:00", "published_display": "25 Apr 2025 00:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Is Adicet Bio (ACET) stock outpacing its medical peers this year?", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxPTkN2dkVTMlZtOU1qNmMzclVvcVo1dVNlN0J4QTQ4U0xScWxCRjdtSElqdUdReDI5a1V0V1ptc004RS1rdDNsMVlkQmx0N0F5MnB3c3J5dUtpLXE3Z3gwaklSb1BYVFk2bEZiSHQ5UGdmekxVdU85Q2hEampKQXpTV2hSbWJYdVBHVm9uSm5GNnpMYnVYX0Q2RmVGYXJVeU95QXpDMVIzdkpRSElfNEhyM0R5akx6S0VpWldlcW9SdEdjMWx0dHFxaEZDeWlTdw?oc=5", "source_name": "MSN", "published_at": "2026-07-13T16:51:12+00:00", "published_display": "13 Jul 2026 16:51", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Adicet Bio, Inc. \u2013 NASDAQ:ACET", "summary": "This page provides financial information for Adicet Bio, Inc. (NASDAQ: ACET), specifically focusing on its forward price-to-earnings ratio. The content appears to be from TradingView, offering a snapshot of financial data and market status for the company.", "url": "https://www.tradingview.com/symbols/NASDAQ-ACET/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-07-11T09:39:49", "published_display": "11 Jul 2026 09:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Adicet Bio (ACET) Proxy filing Summary", "summary": "This article summarizes Adicet Bio's proxy filing, detailing the annual meeting scheduled for June 17, 2026. Key items for shareholder voting include the election of three Class II directors, an advisory vote on executive compensation, and the ratification of KPMG LLP as the inde", "url": "https://quartr.com/events/adicet-bio-inc-acet-proxy-filing_FkPWORTG", "source_name": "Quartr", "published_at": "2026-07-09T17:12:03", "published_display": "09 Jul 2026 17:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Adicet Bio (ACET) Stock Analysis Report | Financials & Insights", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFAxT0x4TVJGRmZ0QmtBMGFjcWFjRGpnMFNESGs5cUM2dm92VVhLUmwtOU55cVdkcjNmVWMwYlcxRlpKcnJnYV9YZjc4X1VuSmhPMGU0?oc=5", "source_name": "Benzinga Espa\u00f1a", "published_at": "2026-07-03T07:00:00+00:00", "published_display": "03 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Adicet Bio, Inc.(NasdaqCM: ACET) added to Russell 3000E Index", "summary": "Adicet Bio, Inc. (NasdaqCM: ACET), a clinical-stage biotechnology company, has been added to the Russell 3000E Index. The company focuses on developing off-the-shelf gamma delta T cells engineered with chimeric antigen receptors (CARs) for autoimmune diseases and solid tumors. It", "url": "https://www.marketscreener.com/news/adicet-bio-inc-nasdaqcm-acet-added-to-russell-3000e-index-ce7f5fdcda8ef226", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T21:09:58", "published_display": "29 Jun 2026 21:09", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Adicet Bio, Inc.(NasdaqCM: ACET) added to Russell 3000E Value Benchmark", "summary": "Adicet Bio, Inc. (NasdaqCM: ACET) has been added to the Russell 3000E Value Benchmark. This news follows earlier announcements that the company was also added to the Russell Microcap Value Benchmark Index and the Russell Microcap Index on June 29, 2026, and the Russell 3000E Inde", "url": "https://www.marketscreener.com/news/adicet-bio-inc-nasdaqcm-acet-added-to-russell-3000e-value-benchmark-ce7f5fddda8df521", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T20:41:48", "published_display": "29 Jun 2026 20:41", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Adicet Bio, Inc.(NasdaqCM: ACET) added to Russell Microcap Value Benchmark Index", "summary": "Adicet Bio, Inc. (NasdaqCM: ACET) has been added to the Russell Microcap Value Benchmark Index. The clinical-stage biotechnology company focuses on developing off-the-shelf gamma delta T cell therapies, with its lead product candidate, ADI-001, targeting autoimmune diseases. This", "url": "https://www.marketscreener.com/news/adicet-bio-inc-nasdaqcm-acet-added-to-russell-microcap-value-benchmark-index-ce7f5fdfd988f621", "source_name": "www.marketscreener.com", "published_at": "2026-06-29T13:40:02", "published_display": "29 Jun 2026 13:40", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Adicet Bio Inc Actuals & Estimates (MUN:1IJ)", "summary": "This article provides an overview of Adicet Bio Inc (MUN:1IJ) stock, including financial actuals and analyst estimates. It covers the company's past performance, future price forecasts, earnings reports, revenue, net income, and employee count. The article also provides details o", "url": "https://www.tradingview.com/symbols/MUN-1IJ/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T19:09:59", "published_display": "26 Jun 2026 19:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ACET Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "The article provides a forecast for Adicet Bio, Inc. (ACET) stock, including analyst price targets, historical performance, and current financial metrics. Analysts have given ACET a max estimate of $100.00 and a min estimate of $18.00. The company's recent stock performance and u", "url": "https://www.tradingview.com/symbols/NASDAQ-ACET/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-26T19:09:59", "published_display": "26 Jun 2026 19:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "1IJ Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast for Adicet Bio Inc (1IJ) stock, including analyst price targets and future predictions. It details the company's past financial performance, upcoming earnings dates, and current employee count. The article also addresses frequently asked questions", "url": "https://www.tradingview.com/symbols/DUS-1IJ/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-26T18:10:27", "published_display": "26 Jun 2026 18:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Adicet Bio Inc Actuals & Estimates (TRADEGATE:1IJ)", "summary": "This article provides financial actuals and estimates for Adicet Bio Inc (TRADEGATE:1IJ), including income statements, balance sheets, cash flow data, and valuations. It also offers analyst forecasts, historical price data, upcoming earnings reports, and other key financial metri", "url": "https://www.tradingview.com/symbols/TRADEGATE-1IJ/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T06:10:27", "published_display": "26 Jun 2026 06:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "12 Health Care Stocks Moving In Thursday's Pre-Market Session", "summary": "This article lists 12 healthcare stocks experiencing significant movement in pre-market trading on Thursday. It details both gainers like Adicet Bio, Bio-Techne, and TELA Bio, noting their percentage increase and market values. Conversely, it also highlights decliners such as ARS", "url": "https://www.benzinga.com/trading-ideas/movers/26/06/60093829/12-health-care-stocks-moving-thursday-s-pre-market-session", "source_name": "Benzinga", "published_at": "2026-06-25T11:40:23", "published_display": "25 Jun 2026 11:40", "sentiment": "positive", "sentiment_pct": 75, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Adicet Bio (ACET) director receives 4,200 stock options at $8.10 strike", "summary": "Adicet Bio director Andrew Sinclair was granted 4,200 stock options at an exercise price of $8.10 per share as part of his board compensation. These options, which expire on June 20, 2036, will vest fully on the earlier of the first anniversary of the grant date or the next annua", "url": "https://www.stocktitan.net/sec-filings/ACET/form-4-adicet-bio-inc-insider-trading-activity-c0c44bfdd479.html", "source_name": "Stock Titan", "published_at": "2026-06-24T18:09:17", "published_display": "24 Jun 2026 18:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Adicet Bio (ACET) CEO Chen Schor receives 55,000 stock options at $8.10", "summary": "Chen Schor, President & CEO of Adicet Bio (ACET), has been granted a new stock option award for 55,000 shares. These options have an exercise price of $8.10 per share and will vest monthly over four years, with potential for accelerated vesting based on specific performance miles", "url": "https://www.stocktitan.net/sec-filings/ACET/form-4-adicet-bio-inc-insider-trading-activity-ddd9b53cd813.html", "source_name": "Stock Titan", "published_at": "2026-06-23T23:09:27", "published_display": "23 Jun 2026 23:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Adicet Bio Inc For: 23 June By Investing.com", "summary": "This article from Investing.com reports the filing of a Form 4 for Adicet Bio Inc. on June 23. Form 4 filings are legally required documents submitted to the SEC by company insiders, like officers and directors, to report changes in their ownership of the company's restricted sto", "url": "https://ca.investing.com/news/stock-market-news/form-4-adicet-bio-inc-for-23-june-93CH-4704405", "source_name": "Investing.com Canada", "published_at": "2026-06-23T23:09:27", "published_display": "23 Jun 2026 23:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Adicet Bio (ACET) grants CSO Blake Aftab 55,000 stock options", "summary": "Adicet Bio, Inc. has granted its Chief Scientific Officer, Blake Aftab, 55,000 stock options with an exercise price of $8.10 per share, expiring on June 18, 2036. These options are compensation-related and will vest over 48 monthly anniversaries of the grant date, with potential ", "url": "https://www.stocktitan.net/sec-filings/ACET/form-4-adicet-bio-inc-insider-trading-activity-4dc47a629a72.html", "source_name": "Stock Titan", "published_at": "2026-06-23T23:09:27", "published_display": "23 Jun 2026 23:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Adicet Bio (ACET) director receives stock options for 4,200 shares at $8.10", "summary": "Adicet Bio director Michael Grissinger was granted stock options for 4,200 shares of common stock at an exercise price of $8.10 per share, expiring on June 20, 2036. This compensation-related grant will vest in full on the earlier of the first anniversary of the grant date or the", "url": "https://www.stocktitan.net/sec-filings/ACET/form-4-adicet-bio-inc-insider-trading-activity-8446e4ea96ab.html", "source_name": "Stock Titan", "published_at": "2026-06-23T20:09:57", "published_display": "23 Jun 2026 20:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Director Katie Peng receives 4,200 Adicet Bio (ACET) stock options at $8.10", "summary": "Adicet Bio director Katie Peng was granted 4,200 stock options with an exercise price of $8.10 per share, set to expire on June 20, 2036. The options will vest fully on the earlier of the first anniversary of the grant date or the next annual stockholders' meeting, provided her c", "url": "https://www.stocktitan.net/sec-filings/ACET/form-4-adicet-bio-inc-insider-trading-activity-8ec43dd497e1.html", "source_name": "Stock Titan", "published_at": "2026-06-23T20:09:27", "published_display": "23 Jun 2026 20:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Director at Adicet Bio (NASDAQ: ACET) receives 4,200 stock options grant", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxOdmJ3d2lqbDg2c0lQSnZvV0pvYkN4UG1RYWc4UXdQVi1QWGJrY3dHc2xTdVZyLUxfWEJJempvRGhjMlVpVi1TbHp0cVlualNEbHBfRFZRekxia2hmYXJMakQ0WjZVYndIN3dmS1JpWnA3Z2FPRXRuckRQQklvR3F3RkJyZ1R5OHFHaHJfN0xqemQ0LWhlWmhkWkpVbXFpUU84VGg2ckQ4d012Rmc5?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Director at Adicet Bio (ACET) awarded 4,200 options at $8.10 strike", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxOclo5S1k0dVhzTnBVUnJoUGcxZjA5d0VnSVZvTnVSXy1SeDFFdENCM0JrSEFDbVRDSGRaeVVERkdDNU9KX0xJY3dWbjZJTHl1ZDhzZmE5X3Uyd1Vtdl9jME1VTDRndktSUkhMNW1HeWNpa1Z3R01paHNMUnpyRVMzbG5WVzRraThMd3VkSmkzWnh0d1hoZE5CbGpJcm8yTlpocFl1d3ZnWlVqTTVf?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Adicet Bio (ACET) investors back board nominees, pay and KPMG at 2026 meeting", "summary": "Adicet Bio, Inc. (ACET) held its 2026 Annual Meeting of Stockholders, where shareholders approved the election of three Class II directors, Jeffrey Chodakewitz, Steve Dubin, and Michael Grissinger, to three-year terms. They also passed a non-binding advisory vote on the compensat", "url": "https://www.stocktitan.net/sec-filings/ACET/8-k-adicet-bio-inc-reports-material-event-ffdcdae26276.html", "source_name": "Stock Titan", "published_at": "2026-06-18T19:40:48", "published_display": "18 Jun 2026 19:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Adicet Bio Inc (ACET) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides an overview of Adicet Bio Inc's (ACET) dividend history and stock split events. It indicates that the company has not distributed any dividends in the past five years but lists several past merger-related stock splits. The company's current market capitaliza", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-acet/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-18T06:39:51", "published_display": "18 Jun 2026 06:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Adicet Bio Inc (ACET) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "The article provides an earnings forecast for Adicet Bio Inc (ACET), indicating a current earnings forecast score of 9.00 and an average price target of $8.00 based on 6 analysts. Most analysts recommend a \"STRONG BUY\" for ACET stock, with a projected upside space of over 348%. T", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-acet/earnings", "source_name": "TradingKey", "published_at": "2026-06-18T05:39:51", "published_display": "18 Jun 2026 05:39", "sentiment": "positive", "sentiment_pct": 72, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ACET: All proposals, including director elections and auditor ratification, were approved by stockholders", "summary": "Adicet Bio, Inc. (ACET) stockholders approved all proposals, including director elections, executive compensation, and auditor ratification, during their 2026 AGM. The meeting established quorum and no questions were raised. Final voting results will be officially filed.", "url": "https://www.tradingview.com/news/urn:summary_document_transcript:quartr.com:3611343:0-acet-all-proposals-including-director-elections-and-auditor-ratification-were-approved-by-stockholders/", "source_name": "TradingView", "published_at": "2026-06-18T04:09:39", "published_display": "18 Jun 2026 04:09", "sentiment": "positive", "sentiment_pct": 68, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Adicet Bio Inc (ACET) Valuation: PE, PB & Fair Value Analysis", "summary": "This article provides a valuation analysis for Adicet Bio Inc (ACET), noting its current valuation score of 8.21, ranking 161 out of 388 in the Biotechnology & Medical Research industry. It highlights the company's P/E ratio of -0.58, which is significantly below its recent high ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-acet/company-valuation", "source_name": "TradingKey", "published_at": "2026-06-17T02:38:56", "published_display": "17 Jun 2026 02:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "10 Health Care Stocks Moving In Monday's Pre-Market Session - Adicet Bio (NASDAQ:ACET), 20/20 Biolabs (NA", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxNY1NkOEFvb2RTcFdiRnp3TVdEQjN1QkdyckY3d2w5VU5QZ3JEVnRaQ001X3FSVWRvSExSMHFqOTNreGM0MXB1d3pCNE9HNW1Ra3pMRDM4R3hhTmFpMERKRXpIZ3hSWmRzU2VCQWUxcThHdEJ0elBEdGRYN3BvRUp0eVlQdDFXNk51YzBTQ0JOSDdTSVlGRVlld0FrdnJJc1NTRXhCanlqSVJkSWZDZjU2NlBGVmo?oc=5", "source_name": "Benzinga", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Adicet Bio teases autoimmune data catalysts, PSMA plans at Jefferies conference", "summary": "The provided article content was empty. Therefore, a summary cannot be generated.", "url": "https://www.msn.com/en-us/health/other/adicet-bio-teases-autoimmune-data-catalysts-psma-plans-at-jefferies-conference/ar-AA24Qz6r?ocid=BingNewsVerp&apiversion=v2&domshim=1&noservercache=1&noservertelemetry=1&batchservertelemetry=1&renderwebcomponents=1&wcseo=1", "source_name": "MSN", "published_at": "2026-06-09T11:40:03", "published_display": "09 Jun 2026 11:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Adicet Bio (ACET) Jefferies Global Healthcare Conference 2026 Summary", "summary": "The article summarizes Adicet Bio's presentation at the Jefferies Global Healthcare Conference 2026, focusing on their gamma delta T cell platform and clinical progress. Key updates include their lead candidate, prula-cel (ADI-001), being evaluated for several autoimmune indicati", "url": "https://quartr.com/events/adicet-bio-inc-acet-jefferies-global-healthcare-conference-2026_FkPWOMcq", "source_name": "Quartr", "published_at": "2026-06-07T15:41:00", "published_display": "07 Jun 2026 15:41", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BPAS - Adicet Bio, Inc. - Common Stock (Nasdaq:ACET) Stock Quote", "summary": "This page provides a stock quote and detailed financial information for Adicet Bio, Inc. (Nasdaq: ACET), including current price, volume, trading ranges, and market capitalization. It also features a comprehensive list of recent news and press releases related to the company's fi", "url": "https://markets.financialcontent.com/bpas/quote?Symbol=NQ%3AACET", "source_name": "FinancialContent", "published_at": "2026-06-06T10:38:56", "published_display": "06 Jun 2026 10:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BPAS - Latest News about Adicet Bio, Inc. - Common Stock (Nasdaq:ACET)", "summary": "This page provides the latest news and press releases concerning Adicet Bio, Inc. (Nasdaq: ACET), detailing various corporate updates, financial results, conference participations, and clinical trial milestones. The stock price for Adicet Bio, Inc. is also displayed, showing a re", "url": "https://markets.financialcontent.com/bpas/quote/news?Symbol=537%3A903118&ChannelType=PRESSRELEASES", "source_name": "FinancialContent", "published_at": "2026-06-05T22:10:07", "published_display": "05 Jun 2026 22:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Are Medical Stocks Lagging Adicet Bio (ACET) This Year?", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxPaTdVLUVzSHFNQnM4ZmN1SmVuNUJkUGJMR3VlMWl1TmVzTllzNl9SZllkaHBraGJ6N1g0THltc2EtSmlubW1aUVhMaXBzQ1JyNUFOSkptRWNVajhVRmVfVTIxLTJza1ZVQ2VKWmQyZlJHMjlJQjRSRXg4c2hYRHc0aGJBZDc5b2hNSGU0OE12TEtjdXktR0k1WjRjY2VXaTZrOFh0Vg?oc=5", "source_name": "Market source", "published_at": "2026-05-28T07:00:00+00:00", "published_display": "28 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Wall Street Analysts Believe Adicet Bio (ACET) Could Rally 319.64%: Here's is How to Trade", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxQTDZkM1d6WFFIM2tCWkJCOVhxM3oyOEpWZ1dMS1Q0bTFWWHlOQ0lrTHFUcXVPTGpmSGY1Vld4ZFZvYjlTSC1MZXZWQWU0Q1NnaTM0Z0Z1dUlqN0k3ZHRkeElJMVBtaFI5bDdVNnFGM2pZUUFsOXFQUjZFMlBWa0s3ZF91dlBEVGYyeG56aGdoSF9IWlVJdF9SR0hHVk1mOGdyeEE?oc=5", "source_name": "Market source", "published_at": "2026-05-25T07:00:00+00:00", "published_display": "25 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ra Capital buys Adicet Bio (ACET) shares worth $1.6 million", "summary": "", "url": "https://news.google.com/rss/articles/CBMivAFBVV95cUxPekE1Z05VTzZvYkNHbGFSNEdiNzdFa01sZVZTbHdsUzRlSFFsSmVoQk5JUHdwN3B3MjFLVkhfZzM1YWRNODVWZm5obGdKMjFETXJITVlGZ1p2el9WUGtUdEQ1YW9ONlVhaDNZQkd1VU8xVVR4NDhxUjctVVJTenJKZ3FUYXJOZzZCVEFXelRSTENWd1h0SE9xUWJRR2diakI3Tllwc2FlMTYxNTg0em1fVXYxQUN1eTQ0X3B1ag?oc=5", "source_name": "Investing.com", "published_at": "2026-04-13T07:00:00+00:00", "published_display": "13 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Adicet Bio (ACET) Upgraded to Buy: Here's Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPa1pKWmU5MWRTeXZPcDhnZldhM0tjNjdtNXpacEdaUEFrUDZUZmRseXVKUFJGcHRCVGdUcF9maldZMWFLSTJ6czlLRUxTdmxHOVVreHAxU2JLRTRoR1Y2S2VNb0lFUm5pR1ctZ1M5X3l0Ym1NMnc5T1VvYmVIcl9WUmxzYnk3SXV4Z0gxMEVMZDBHVXR4ZjZJNQ?oc=5", "source_name": "Market source", "published_at": "2026-03-24T07:00:00+00:00", "published_display": "24 Mar 2026 07:00", "sentiment": "positive", "sentiment_pct": 84, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Orbimed advisors buys Adicet Bio (ACET) shares worth $5 million", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxPU0Z4blctSWJnbnFJTlVuWDAyYUU2a2NYWGs5T015aW9DQWh5VldVbmhMX0J4UGEyRW5ua1h5U2F5YmZyTW54LXhPaFM4Q1B4aVdHRGRNekphZnBEZjB4VU5CWmwxcWZxbzJsVE02bXRDeFdNNU5QN241SFU0YUlJSF9vRjV6VjdoZFNEZFJ6Ykw4OElsNmEzX256TUU5dUxrWXRZMmdBZWdyVjBCeWsxc2ljREhPdk1wdlRjeElmb0N3clE?oc=5", "source_name": "Investing.com", "published_at": "2025-10-10T07:00:00+00:00", "published_display": "10 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Adicet Bio (ACET) Upgraded to Buy: Here's What You Should Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMif0FVX3lxTE5fOFRRbGF4dWFMbS1KS2xPOTd6c2FIMWgxWUhWbXVONVZ1SWdndEJFQ0x0My1PNmgteW1xQ1p3RTkxR29KYUNVSDZNd0xqZkJrcjBzMDFYVWtUZlp5c2QyNHMtV01uNUdubVNUVDU1aUYzMEl0MXdBQVNRdWlNRVU?oc=5", "source_name": "Market source", "published_at": "2025-09-30T07:00:00+00:00", "published_display": "30 Sep 2025 07:00", "sentiment": "positive", "sentiment_pct": 84, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Adicet Bio (ACET) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTFBHMEx6VmJMMGlnNDdxT1VWQVFOdHdRd3FsblBBR2g3OW5yUVI2c3o2MkxfdFhjbWFjaGYzUjdUSEE3LVhlSVVUeUl1WFcyWjV3YWlr?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-25T00:00:05+00:00", "published_display": "25 Apr 2025 00:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 84, "total_relevant": 45, "sentiment_summary": {"positive": 10, "negative": 1, "neutral": 34, "score": 55, "total": 45, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 81, "events": [{"event": "general", "label": "Market update", "weight": 14.3, "count": 26}, {"event": "earnings", "label": "Earnings", "weight": 6.6, "count": 14}, {"event": "analyst", "label": "Analyst action", "weight": 2.2, "count": 4}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}], "positive_events": 10, "negative_events": 1}, "market_context": {"has_market_context": true, "latest_close": 8.83, "latest_week": "2026-07-10", "one_week_move": -1.9, "four_week_move": 9.7, "twelve_week_move": 7.4, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 0.969426, "market_dynamics_buy_signal": false, "relative_strength": -20.920538, "fair_value_gap": -52.3, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "undecided", "expectation_probability": 47.2159, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "-1.9% over one week, +9.7% over four weeks, trend active, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 64, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 9}, {"label": "Stock Titan", "count": 9}, {"label": "TradingView", "count": 7}, {"label": "www.marketscreener.com", "count": 3}, {"label": "TradingKey", "count": 3}, {"label": "MSN", "count": 2}, {"label": "Quartr", "count": 2}, {"label": "Benzinga", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 37}, {"label": "Industry context", "count": 8}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 26}, {"label": "Earnings", "count": 14}, {"label": "Analyst action", "count": 4}, {"label": "Deals and strategy", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "55/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "81/100 classification confidence."}, {"label": "Company focus", "value": "37", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "-1.9% over one week, +9.7% over four weeks, trend active, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Is Adicet Bio (ACET) stock outpacing its medical peers this year?"}], "updated_at": "2026-07-16T03:30:35.746411+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}